Recombinant Human SUMF1 Protein，His

SUMF1, or Sulfatase Modifying Factor 1, is a crucial post-translational modification enzyme that plays a significant role in the activation of sulfatases by catalyzing the conversion of a specific amino acid, cysteine, to formylglycine. This modification is essential for the proper function of sulfatases, which are a family of enzymes involved in the hydrolysis of sulfate esters from biomolecules. Dysfunctions or deficiencies in sulfatases are linked to several genetic disorders, including multiple sulfatase deficiency (MSD), which can lead to severe developmental issues and metabolic dysfunctions. Understanding SUMF1 and its mechanisms is vital for unraveling the complexities of sulfatase-related diseases and their potential therapeutic interventions. Research into SUMF1 has gained momentum due to its implications in enzyme regulation, cellular signaling, and its potential role in drug development, wherein enhancing or inhibiting SUMF1 activity could provide novel treatment avenues for disorders associated with sulfatase dysfunction. This burgeoning field of study highlights the significance of SUMF1 in both basic biological processes and clinical implications, as it provides insights into the intricate network of post-translational modifications and enzymatic functions necessary for maintaining cellular homeostasis. Furthermore, advances in biotechnological techniques have enabled researchers to explore recombinant SUMF1 proteins, facilitating a deeper understanding of its structure-function relationship and offering possibilities for therapeutic applications. The continued investigation of SUMF1 will not only contribute to our fundamental understanding of enzymatic functions but also pave the way for innovative strategies in treating sulfatase-related diseases.